Filing Details
- Accession Number:
- 0001209191-17-051249
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-05 17:01:08
- Reporting Period:
- 2017-08-31
- Accepted Time:
- 2017-09-05 16:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-31 | 24,333 | $115.09 | 289,368 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-09-01 | 6,364 | $5.50 | 295,732 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-01 | 22,500 | $130.04 | 273,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-01 | 6,364 | $0.00 | 6,364 | $5.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 243,355 | 2023-01-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,186 | Indirect | Nick Leschly 2001 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- The range of prices for the transaction reported on this line was $115.00 to $115.65. The average weighted price was $115.0890. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $130.00 to $130.30. The average weighted price was $130.0437. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vest over a four-year period, at a rate of twenty-five percent (25%) on May 1, 2014, and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
